Is Ondansetron Safe During Pregnancy
Status
cautionReason
Pregnancy data are limited and mixed; use only if needed and after provider review.
Drug Information
Safe Amount
Dosage must be determined by your provider based on individual risk/benefit.
Effects
- Pregnancy
- Used for nausea and vomiting in pregnancy when other options fail; first-trimester use needs extra caution.
- Mother
- May cause QT prolongation or serious heart rhythm problems, especially at higher doses or with risk factors.
- Baby
- Most official summaries do not show a clear increase in overall birth defects, but data are limited and mixed.
Trimester Notes
- 1st Trimester
- Use extra caution in the first trimester because some studies raised concern about possible birth-defect risk, while others did not.
- 2nd Trimester
- Can be considered if needed after other treatments fail, with provider guidance.
- 3rd Trimester
- No special official trimester warning was found in the cited sources, but provider review is still needed.
Risk-Benefit Note
If nausea or vomiting is severe, the benefit of treating the mother may outweigh the possible fetal risk. Do not stop or switch without your prescriber's guidance.
Conditions & Warnings
- Consult OB/GYN or prescriber
- Prescription medicine: review with your provider before starting, stopping, or continuing
- Extra caution if you have long QT syndrome, low potassium or magnesium, heart failure, or take other QT-prolonging drugs
- Use the lowest effective dose for the shortest time under provider guidance
Alternatives
- pyridoxine (vitamin B6)
- doxylamine-pyridoxine
- metoclopramide
- non-drug measures like small frequent meals and fluids
References
- FDA label for ZOFRAN (ondansetron hydrochloride)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020103s035_020605s019_020781s019lbl.pdf - FDA Ondansetron Clinical BPCA
https://www.fda.gov/files/drugs/published/N20-007S035-Ondansetron-Clinical-BPCA.pdf - MotherToBaby Fact Sheet: Ondansetron (Zofran)
https://www.ncbi.nlm.nih.gov/books/NBK582886/ - StatPearls: Ondansetron
https://www.ncbi.nlm.nih.gov/books/NBK499839/